These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29720767)

  • 1. Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Thal SB; Lommen MJJ
    J Contemp Psychother; 2018; 48(2):99-108. PubMed ID: 29720767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder.
    White CM
    Ann Pharmacother; 2014 Jul; 48(7):908-915. PubMed ID: 24740469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.
    Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC
    Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
    Bahji A; Forsyth A; Groll D; Hawken ER
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
    Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
    J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mending Invisible Wounds: The Efficacy and Legality of MDMA-Assisted Psychotherapy in United States' Veterans Suffering with Post-Traumatic Stress Disorder.
    Perry J
    J Law Health; 2016; 29(2):272-301. PubMed ID: 30889330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Gorman I; Belser AB; Jerome L; Hennigan C; Shechet B; Hamilton S; Yazar-Klosinski B; Emerson A; Feduccia AA
    J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
    Yang J; Wang N; Luo W; Gao J
    Psychiatry Res; 2024 Jun; 339():116043. PubMed ID: 38896930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
    Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA
    J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
    Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.
    Oeri HE
    J Psychopharmacol; 2021 May; 35(5):512-536. PubMed ID: 32909493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.
    Baldo BA
    Arch Toxicol; 2024 May; ():. PubMed ID: 38743292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
    Smith KW; Sicignano DJ; Hernandez AV; White CM
    J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
    Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
    Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.